Combining exercise with GLP-1 RA liraglutide results in significant weight loss while preserving bone health in adults with obesity.
Novo shells out $1.1bn to buy Cardior to expand cardiovascular pipeline
Share this article Cardiovascular is one of the areas Novo Nordisk plans to establish its presence by 2025, as per the company’s Q4 2023 quarterly